Expression and significance of FRA-1 in non-small-cell lung cancer

Cancer Investigation

Volumn 27, Issue 3, 2009, Pages 353-359

  Ma, Kai ^a   Chang, Dong ^a   Gong, Min ^a   Ding, Fang ^b   Luo, Aiping ^b   Tian, Feng ^a   Liu, Zhihua ^b   Wang, Tianyou ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

Cancer biomarkers; Gene expression; Lung cancer; Prognostic studies

Indexed keywords

CISPLATIN; TRANSCRIPTION FACTOR FRA 1; PROTEIN C FOS;

ADULT; AGED; ARTICLE; BRONCHUS MUCOSA; CANCER GROWTH; CANCER STAGING; CARCINOGENESIS; CONTROLLED STUDY; CYTOPLASM; DOWN REGULATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SURVIVAL; WESTERN BLOTTING; CHEMISTRY; LUNG TUMOR; MIDDLE AGED; MORTALITY; PATHOLOGY; PHYSIOLOGY; TISSUE MICROARRAY;

ADULT; AGED; BLOTTING, WESTERN; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-FOS; TISSUE ARRAY ANALYSIS;

EID: 63349105245     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.1080/07357900802254008     Document Type: Article

References (38)

1. Shaulian, E.; Karin, M. AP-1 in cell proliferation and survival. Oncogene 2001, 20(19), 2390-2400.
2. Tulchinsky, E. Fos family members: regulation, structure, and role in oncogenic transformation. Histol Histopathol 2000, 15(3), 921-928. (Pubitemid 30488571)
3. Jochum, W.; Passegué, E.; Wagner, E.F. AP-1 in mouse development and tumorigenesis. Oncogene 2001, 20(19), 2401-2412.
4. van Dam, H.; Castellazzi, M. Distinct roles of Jun: Fos and Jun: ATF dimers in oncogenesis. Oncogene 2001, 20(19), 2453-2464. (Pubitemid 32531302)
5. Shaulian, E.; Karin, M. AP-1 as a regulator of cell life and death. Nat Cell Biol 2002, 4(5), E131-E136. (Pubitemid 34521026)
6. Wisdom, R.; Verma, I.M. Transformation by Fos proteins requires a C-terminal transactivation domain. Mol Cell Biol 1993, 13(12), 7429-7438. (Pubitemid 23354267)
7. Prusty, B.K.; Das, B.C. Constitutive activation of transcription factor AP-1 in cervical cancer and suppression of human papilomavirus (HPV) transcription and AP-1 activity in HeLa cell by curcumin. Int J Cancer 2005, 113(6), 951-960.
8. Kustikova, O.; Kramerov D.; Grigorian, M.; Berezin, V.; Bock, E.; Lukanidin, E.; et al. Fra-1 induces morphological transformation and increases in vitro invasiveness and motility of epithelioid adenocarcinoma cells. Mol Cell Biol 1998, 18(12), 7095-7105.
9. Zajchowski, D.A.; Bartholdi, M.F.; Gong, Y.; Webster, L.; Liu, H.L.; Munishkin, A.; et al. Identification of gene expression profiles that predict the aggressive behavior of breast cancer cells. Cancer Res 2001, 61(13), 5168-5178.
10. Belguise, K.; Kersual, N.; Galtier, F.; Chalbos, D. FRA-1 expression level regulates proliferation and invasiveness of breast cancer cells. Oncogene 2005, 24(8), 1434-1444. (Pubitemid 40343123)
11. Chiappetta, G.; Ferraro, A.; Botti, G.; Monaco, M.; Pasquinelli, R.; Vuttariello, E.; et al. Fra-1 protein overexpression is a feature of hyperplastic and neoplastic breast disorders. BMC Cancer 2007, 7, 17.
12. Hu, Y.C.; Lam K.Y.; Law, S.; Wong, J.; Srivastava, G. Identification of differentially expressed genes in esophageal squamous cell carcinoma (ESCC) by cDNA expression array: overexpression of Fra-1, Neogenin, Id-1, and CDC25B genes in ESCC. Clin Cancer Res 2001, 7(8), 2213-2221. (Pubitemid 32751617)
13. Chiappetta, G.; Tallini, G.; De Biasio, M.C.; Pentimalli, F.; de Nigris, F.; Losito, S.; et al. Fra-1 expression in hyperplastic and neoplastic thyroid diseases. Clin Cancer Res 2000, 6(11), 4300-4306.
14. Vial, E.; Sahai, E.; Marshall, C.J. ERK-MAPK signaling coordinately regulates activity of Rac1 and RhoA for tumor cell motility. Cancer Cell 2003, 4(1), 67-79.
15. Wang, H.L.; Wang, J.; Xiao, S.Y.; Haydon, R.; Stoiber, D.; He, T.C.; et al. Elevated protein expression of cyclin D1 and Fra-1 but decreased expression of c-Myc in human colorectal adenocarcinomas overexpressing beta-catenin. Int J Cancer 2002, 101(4), 301-310.
16. Serewko, M.M.; Popa, C.; Dahler, A.L.; Smith, L.; Strutton, G.M.; Coman, W.; et al. Alterations in gene expression and activity during squamous cell carcinoma development. Cancer Res 2002, 62(13), 3759-3765. (Pubitemid 34728858)
17. Tchernitsa, O.I.; Sers, C.; Zuber, J.; Hinzmann, B.; Grips, M.; Schramme, A.; et al. Transcriptional basis of KRAS oncogene-mediated cellular transformation in ovarian epithelial cells. Oncogene 2004, 23(26), 4536-4555.
18. Hapke, S.; Kessler, H.; Luber, B.; Benge, A.; Hutzler, P.; Hofler, H.; et al. Ovarian cancer cell proliferation and motility is induced by engagement of integrin alpha(v)beta3/Vitronectin interaction. Biol Chem 2003, 384(7), 1073-1083.
19. Jemal, A.; Siegel, R.; Ward, E.; Murray, T.; Xu, J.; Thun, M.J. Cancer statistics, 2007. CA Cancer J Clin 2007, 57(1), 43-46.
20. Birrer, M.J.; Alani, R.; Cuttitta, F.; Preis, L.H.; Sabich, A.L.; Sanders, D.A.; et al. Early events in the neoplastic transformation of respiratory epithelium. J Natl Cancer Inst Monogr 1992, 13, 31-37.
21. Jochum, W.; David, J.P.; Elliott, C.; Wutz, A.; Plenk, H., Jr.; Matsuo, K.; et al. Increased bone formation and osteosclerosis in mice overexpressing the transcription factor Fra-1. Nat Med 2000, 6(9), 980-984.
22. Patterson, T.; Vuong, H.; Liaw, Y.S.; Wu, R.; Kalvakolanu, D.V.; Reddy, S.P. Mechanism of repression of squamous differentiation marker, SPRR1B, in malignant bronchial epithelial cells: role of critical TRE-sites and its transacting factors. Oncogene 2001, 20(5), 634-644.
23. Sandhu, H.; Dehnen, W.; Roller, M.; Abel, J.; Unfried, K. mRNA expression patterns in different stages of asbestos-induced carcinogenesis in rats. Carcinogenesis 2000, 21(5), 1023-1029.
24. Shukla, A.; Timblin, C.R.; Hubbard, A.K.; Bravman J.; Mossman, B.T. Silica-induced activation of c-Jun-NH2-terminal amino kinases, protracted expression of the activator protein-1 proto-oncogene, Fra-1, and S-phase alterations are mediated via oxidative stress. Cancer Res 2001, 61(5), 1791-1795.
25. Zhang, Q.; Adiseshaiah, P.; Reddy, S.P. Matrix metalloproteinase/ epidermal growth factor receptor/mitogen-activated protein kinase signaling regulate Fra-1 induction by cigarette smoke in lung epithelial cells. Cell Mol Biol 2005, 32(1), 72-81.
26. Risse-Hackl, G.; Adamkiewicz, J.; Wimmel, A.; Schuermann, M. Transition from SCLC to NSCLC phenotype is accompanied by an increased TRE-binding activity and recruitment of specific AP-1 proteins. Oncogene 1998, 16(23), 3057-3068. (Pubitemid 28297728)
27. Adiseshaiah, P.; Lindner, D.J.; Kalvakolanu, D.V.; Reddy, S.P. Fra-1 proto-oncogene induces lung epithelial cell invasion and anchorage-independent growth in vitro, but is insufficient to promote tumor growth in vivo. Cancer Res 2007, 67(13), 6204-6211.
28. Moutain, C.F. Revisions in the international system for staging lung cancer. Chest 1997, 111(6), 1710-1717. (Pubitemid 27260107)
29. Chang, D.; Wang, T.Y.; Li, H.C.; Wei, J.C.; Song, J.X. Prognostic significance of PTEN expression in esophageal squamous cell carcinoma from Linzhou City, a high incidence area of northern China. Dis Esoph 2007, 20(6), 491-496.
30. Fleischmann, A.; Hafezi, F.; Elliott, C.; Remé, C.E.; Rüther, U.; Wagner, E.F. Fra-1 replaces c-Fos-dependent functions in mice. Genes Dev 2000, 14(21), 2695-2700. (Pubitemid 32531196)
31. Bamberger, A.M.; Methner, C.; Lisboa, B.W.; Städtler, C.; Schulte H,M.; Löning, T.; et al. Expression pattern of the AP-1 family in breast cancer: association of FosB expression with a well-differentiated, receptor-positive tumor phenotype. Int J Cancer 1999, 84(5), 533-538.
32. Gruda, M.C.; Kovary, K.; Metz, R.; Bravo, R. Regulation of Fra-1 and Fra-2 phosphorylation differs during the cell cycle of fibroblasts and phosphorylation in vitro by MAP kinase affects DNA binding activity. Oncogene 1994, 9(9), 2537-2547.
33. Zoumpourlis, V.; Papassava, P.; Linardopoulos, S.; Gillespie, D.; Balmain, A.; Pintzas, A. High levels of phosphorylated c-Jun, Fra-1, Fra-2, and ATF-2 proteins correlate with malignant phenotypes in the multistage mouse skin carcinogenesis model. Oncogene 2000, 19(35), 4011-4021. (Pubitemid 30676498)
34. Travis, W.D.; Brambilla, E.; Muller-Hermelinnk, H.K.; Harris, C.C.. World Health Organization Classification of Tumours. Pathology and Genetics of tumours of the lung, pleura, thymus, and heart. Lyon: IARC Press, 2004.
35. Andersen, H.; Mahmood, S.; Tkach, V.; Cohn, M.; Kustikova, O.; Grigorian, M.; et al. The ability of Fos family members to produce phenotypic changes in epitheloid cells is not directly linked to their transactivation potentials. Oncogene 2002, 21(31), 4843-4848.
36. Vallone, D.; Battista, S.; Pierantoni, G.M.; Fedele, M.; Casalino, L.; Santoro, M.; et al. Neoplastic transformation of rat thyroid cells requires the JunB and Fra-1 gene induction, which is dependent on the HMGI-C gene product. EMBO J 1997, 16(17), 5310-5321.
37. Volm, M.; Koomagi, R.; Mattern, J.; Efferth, T. Expression profile of genes in non-small-cell lung carcinomas from long-term surviving patients. Clin Cancer Res 2002, 8(6), 1843-1848. (Pubitemid 34633744)
38. Song, Y.; Song, S.; Zhang, D.; Zhang, Y.; Chen, L.; Qian, L.; et al. An association of a simultaneous nuclear and cytoplasmic localization of Fra-1 with breast malignancy. BMC Cancer 2006, 6, 298.